BlackRock Group’s Auspex Pharmaceuticals ASPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-5,796
Closed -$581K – 3006
2015
Q1
$581K Buy
+5,796
New +$386K ﹤0.01% 2132
2014
Q3
– Sell
-971
Closed -$22K – 2923
2014
Q2
$22K Buy
+971
New +$21.2K ﹤0.01% 2760

BlackRock Group's ASPX Position: Q2 2015 in Review

BlackRock Group sold out of Auspex Pharmaceuticals (ASPX) in Q2 2015, closing a stake of 5,796 shares — an estimated $581K sold.

BlackRock Group first reported a position in ASPX in Q2 2014 and held it in 2 quarters. The position peaked at $581K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • BlackRock Group reported no remaining Auspex Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • BlackRock Group sold 5,796 Auspex Pharmaceuticals shares in Q2 2015, an estimated $581K.
  • BlackRock Group first reported a position in Auspex Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • BlackRock Group's Auspex Pharmaceuticals position peaked at $581K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held Auspex Pharmaceuticals as of Q2 2015.

Based on BlackRock Group's 13F filing for Q2 2015, filed 7 Aug 2015.